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M. A. Riddell1*, J. A. Dunbar2, P. Absetz3, R. Wolfe1, H. Li1,4, M. Brand1, Z. Aziz1,5, B. Oldenburg1,5 and the Australasian
Peers for Progress Diabetes Project Investigators
Abstract
Background: The 2013 Global Burden of Disease Study demonstrated the increasing burden of diabetes and the
challenge it poses to the health systems of all countries. The chronic and complex nature of diabetes requires
active self-management by patients in addition to clinical management in order to achieve optimal glycaemic
control and appropriate use of available clinical services. This study is an evaluation of a “real world” peer support
program aimed at improving the control and management of type 2 diabetes (T2DM) in Australia.
Methods: The trial used a randomised cluster design with a peer support intervention and routine care control
arms and 12-month follow up. Participants in both arms received a standardised session of self-management
education at baseline. The intervention program comprised monthly community-based group meetings over
12 months led by trained peer supporters and active encouragement to use primary health care and other
community resources and supports related to diabetes. Clinical, behavioural and other measures were collected at
baseline, 6 and 12 months. The primary outcome was the predicted 5 year cardiovascular disease risk using the
United Kingdom Prospective Diabetes Study (UKPDS) Risk Equation at 12 months. Secondary outcomes included
clinical measures, quality of life, measures of support, psychosocial functioning and lifestyle measures.
Results: Eleven of 12 planned groups were successfully implemented in the intervention arm. Both the usual care
and the intervention arms demonstrated a small reduction in 5 year UKPDS risk and the mean values for
biochemical and anthropometric outcomes were close to target at 12 months. There were some small positive
changes in self-management behaviours.
Conclusions: The positive changes in self-management behaviours among intervention participants were not
sufficient to reduce cardiovascular risk, possibly because approximately half of the study participants already had
quite well controlled T2DM at baseline. Future research needs to address how to enhance community based
programs so that they reach and benefit those most in need of resources and supports to improve metabolic
control and associated clinical outcomes.
Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12609000469213. Registered 16
June 2009.
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Background
Recent estimates from the 2013 Global Burden of Dis-
ease Study demonstrate the continued increasing health
burden of diabetes and the challenge it poses for the
health systems of all countries [1]. Cardiovascular dis-
ease (CVD) is a leading cause of death associated with
type 2 diabetes (T2DM) with more than double the risk
of CVD-related mortality, compared to those with
normal blood glucose levels [2]. In Australia in 2011, for
those cases in which diabetes was listed as the under-
lying cause of death, chronic heart disease (CHD) was
associated in 64 % of deaths, and where CHD was listed
as the underlying cause of death, diabetes was associated
in approximately 24 % of deaths [3]. The United
Kingdom Prospective Diabetes Study (UKPDS) indicated
that optimal glycaemic and blood pressure control were
associated with a reduced risk of complications [4, 5].
Therefore programs which support the adoption of self-
management behaviours to improve glycaemic control,
reduce blood pressure and other clinical measures to re-
duce the risk of complications are required.
The chronic and complex nature of T2DM requires
active self-management by the person with the condition
in order to achieve optimal glycaemic control, appropri-
ate use of available clinical services, and other resources
and supports. This requires adoption of self-care behav-
iours and key lifestyle behaviours to promote optimal
glycaemic and blood pressure control, smoking cessa-
tion, diet, regular physical activity, medication adherence
and monitoring of blood glucose levels (BGL).
Peer support delivered via community based programs
may assist people with diabetes to improve their gly-
caemic control [6–9]. Indeed, Fisher et al. propose that
peer support can assist with daily diabetes management,
improve linkages with clinical care providers and provide
ongoing emotional and social support [10]. Several stud-
ies, published subsequent to the conduct of this study,
have reported the provision of peer support to people
with diabetes in a variety of clinical and community set-
tings and in different countries [7, 8, 11–18]. Several of
these have looked at glycated haemoglobin (HbA1c) as
the outcome and a number have reported a reduction in
HbA1c [7, 8, 18–20]. It is likely that in one of these
studies the improvement resulted from insulin initiation
[21], and in another, the reduction was only evident in a
selected population [19]. A further two studies examined
the effects of group-based support, but found no signifi-
cant improvements in HbA1c [15, 16], however group
based peer support, as delivered by Simmons et al., re-
sulted in significant reduction of systolic blood pressure
associated with a relative reduction in myocardial infarc-
tion of 2 – 4 % and stroke of 4–6 % [15]. Furthermore,
the added value of peer support for patients already re-
ceiving or having access to adequate clinical care may
not lead to additional clinical benefits [22]. A secondary
analysis of the study by Thom et al. [8] revealed that
those participants with poorer glycaemic control benefit-
ted more from peer support compared to those partici-
pants with better glycaemic control [23].
Other studies have examined peer support delivery
mechanisms, for example, in one study, telephone-based
peer support did not improve the cardiovascular out-
comes over and above integrated care delivered by using
a web-based quality improvement program, although it
did reduce both distress and hospitalizations among
those initially more distressed [11]. Another study dem-
onstrated reductions in HbA1c for those receiving peer
led group based peer support and those receiving sup-
port via telephone-based outreach program delivered by
community health workers after a 6 month diabetes self-
management education (DSME), however, sustained
benefits were only apparent in the group based peer led
support recipients [17]. A recent meta-analysis of 13
randomised control trials of peer support to improve
glycaemic control in patients with T2DM concluded that
receipt of peer support significantly contributed to a re-
duction in HbA1c [24]. Furthermore, trials in which
contact between peers and supporters were moderate or
higher in frequency showed a greater and more signifi-
cant effect size compared to programs in which the con-
tact frequency was low.
Although there is now some good evidence that peer
support can contribute to improving the clinical out-
comes for those with diabetes and other chronic condi-
tions [9, 25], several studies highlight that peer support
may not achieve clinical benefits for those already
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receiving high quality clinical care [11, 22] or those
already in moderately good control [15]. Furthermore, it
is not very clear how variations in contextual and other
factors might also impact on implementation and thereby,
clinical and other health outcomes. Such factors might in-
clude the target population, health care systems and/or dif-
ferences in community settings and contexts, intervention
design (e.g., contents and components) and the intensity
and fidelity of program delivery (e.g., peer supporter train-
ing and competence in delivery). There is an important
need for research to understand more about the import-
ance of and/or interplay among these different factors.
In 2008, the Peers for Progress, a program conducted
under the auspices of the American Academy of Family
Physicians Foundation, supported eight studies to inves-
tigate and expand the evidence base for peer support
using different approaches to program design and deliv-
ery in USA, Australia, Hong Kong and United Kingdom.
All programs were encouraged to pursue standardisation
by function rather than content [6, 26, 27], with the
agreed upon core functions, being: 1) assistance in daily
management, that is, assisting with the” how” of daily
self-management); 2) providing social and emotional
support to individuals; 3) promoting and supporting
regular linkage to clinical care; and finally, 4) provision
of ongoing and sustained support to assist with the life-
long needs of diabetes self-care management.
The Australasian Peers for Progress (PfP) Project was
undertaken in collaboration with Diabetes Australia-Vic
(DA-Vic), the primary diabetes NGO in the Australian
state Victoria. DA-Vic already had a pre-existing peer
support program which primarily focused on bringing
people with diabetes together to share their knowledge
and experiences. However, the Peers for Progress pro-
gram was designed to provide more structured support
and assistance to the participants in the groups by focus-
ing on key self-management behaviours and goals and
by providing structured training and support to the peer
supporters to deliver this kind of program. Therefore,
we aimed to evaluate if a more structured peer support
program would result in significant clinical and self-
management outcomes. Following the earlier publication
of the study protocol [28], this paper now reports on the
12-month outcomes of the program on the control and
self-management of T2DM among program participants,
as well as some key findings from the evaluation of pro-
gram implementation.
Methods
Study design and setting
The published study protocol for this cluster randomised
controlled trial of a group-based peer support program
was implemented and evaluated in accordance with the
requirements of the Consolidated Standards of Reporting
Trials (CONSORT) statement and its extension to
cluster randomised trials [28, 29]. Trial participants
were recruited from a national diabetes registry of
more than one million Australians with diabetes, the
Australian National Diabetes Services Scheme (NDSS)
[30]. Twenty-four geographic communities within the
state of Victoria in Australia (Local Government
Authorities (LGAs)) were selected, from which study
participants were recruited. The project received ethics
approval from the Monash University Human Research
Ethics committee (MUHREC) Project number CF09/
1692 – 2009000920.
Recruitment and allocation
We approached participants from Australia’s NDSS Regis-
try if they had been registered for more than 12 months,
resided in one of the selected LGAs and were aged be-
tween 25 – 75 years. Interested recipients were contacted
by a member of the project team. Exclusion criteria in-
cluded any current medical or related condition likely to
prevent study participation over a 12 month period and/
or poor comprehension in English. We aimed to recruit
an average of 10 – 15 participants and two peer sup-
porters with diabetes from each of the 24 study locations
(“clusters”). For each of three of the eight state health
regions equal numbers of groups (n = 4) were randomly
allocated to receive the intervention and usual care. In
summary, 24 groups (clusters) were allocated to either
intervention or usual care. All participants were provided
with the anthropometry and pathology results of their
baseline, 6 and 12 month testing, and an accompanying
letter encouraging them to share the results with their
clinical team.
Diabetes self-management education
Prior to randomisation, all enrolled participants were in-
vited to attend a 7-hour diabetes self-management edu-
cation (DSME) course that was delivered by credentialed
diabetes educators and dieticians from DA-Vic. The
DSME program presented basic disease information
about diabetes and its clinical management, the key
component being self-management practices including
diet and physical activity, prevention and management
of disease complications, and medications. The partici-
pants in this program received a comprehensive manual.
The purpose of this manual was to supplement and
reinforce information received during the DSME session.
For those who could not attend the face-to-face course,
an education manual and an educational DVD, filmed
during one of the program education sessions and sup-
plemented with visual material, was provided to these
participants. Participants were asked to complete a brief
evaluation form at the end of the education session rat-
ing their general satisfaction with the session.
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Intervention program
The intervention program comprised four inter-related
components that have been previously described in
detail [28]: 1) assistance with the” how” of daily self-
management; 2) provision of social and emotional sup-
port; 3) promotion and support of regular linkage to
clinical care; and 4) provision of ongoing and sustained
support to assist with the lifelong needs of diabetes self-
management. Volunteer peer supporters led a monthly
community-based group meeting for participants, and
contact between supporters and participants outside
these sessions was also encouraged and facilitated. Meet-
ings were scheduled and organised by the supporters in
consultation with group members. Prior to each meet-
ing, participants received a brief phone call from the
peer supporter reminding them of the upcoming meet-
ing and seeking their intention to attend. Meetings were
scheduled for 90 minutes and meeting content and de-
livery was based on the guidelines, provided in the peer
supporter handbook, with these being delivered in con-
sultation with group members. Each program session
provided a list of suggested meeting topics and issues
which focused on the key diabetes self-management be-
haviours, ways to implement socio-behavioural strategies
such as goal setting and monitoring into daily life as well
as to improve participants’ “links” with clinical care. A
regular review of their clinical targets - and also the
utilization of other appropriate community resources
and supports were also incorporated into the meetings.
Groups were especially encouraged to; 1) use all of the
available information resources; 2) arrange visits to their
group meetings by local health care professionals such
as dietitians and diabetes educators; and 3) participate in
shared activities with each other outside of the group
meetings such as walks, tai-chi or other exercise classes
as well as social gatherings. A bi-monthly newsletter
from the project team to group members contained pro-
ject news, group profiles and photos, recipes and other
information to supplement the group meetings.
For delivery of the program, the peer supporters re-
ceived two and a half days of training from a creden-
tialed diabetes nurse educator experienced in group
facilitation and effective communication as previously
described [28]. Briefly peer supporter training aimed to
equip supporters with communication and group facili-
tation skills. This training aimed to help them support
their group members to tell their stories, set goals, prob-
lem solve, increase awareness and linkages with the
available health system, optimize self-management be-
haviours, including glucose monitoring, dietary changes
and physical activity, as well as provide emotional sup-
port. Peer supporters were also supported by the project
team through weekly teleconferences, to which they
were asked to attend at least once per month. Follow-up
notes and actions were provided to all supporters via a
weekly email.
Usual care
Apart from individualised feedback on clinical measures
collected as part of the baseline, 6 and 12 month assess-
ments and participation in the diabetes education ses-
sion, participants in usual care were offered no other
formal support for the duration of the research trial.
Measurement and evaluation
Participants underwent anthropometric measurements
by trained research support staff according to the WHO
STEPwise approach to Surveillance (STEPS) protocol
[31] with some minor modifications as previously de-
scribed [28]. Additionally participants completed a self-
administered survey at baseline, 6 and 12 months after
the start of the intervention seeking information on
demographic, clinical, behavioural, quality of life (EQ-5D
[32], diabetes distress (DDS-4) [33]), depression (PHQ-9
[34]) diabetes self-care [35], satisfaction with diabetes
support [36] and diabetes services utilisation (GPAQ ver
2.1 [37]) as previously described [28]. Participants were
provided with a pathology request form to obtain blood
tests at a local laboratory including HbA1c, total Choles-
terol (TC), high-density lipoprotein (HDL), low-density
lipoprotein (LDL), TC/HDL ratio, triglycerides at each
time point. Results were returned to the project team;
they were then provided to the participant with a letter
suggesting they also share the results with their medical
practitioner. Laboratories were accredited by National
Association of Testing Authorities (http://www.nata.co-
m.au/nata/) and all methods for determining HbA1c%
were National Glycohemoglobin Standardization Pro-
gram (NGSP) approved (http://www.ngsp.org/). HbA1c
% measurements have been converted to the new Inter-
national Federation of Clinical Chemistry (IFCC) unit
(mmol/mol) [38] and are presented in parentheses for
this publication.
Data analysis
The primary outcome measure was cardiovascular dis-
ease risk at 12 months using the United Kingdom Pro-
spective Diabetes Study (UKPDS) 5 yr risk calculation
[39]. A sample size of 100 participants in each arm of
the study at 12 months follow up was calculated as being
sufficient to detect a mean change of −2.0 % in the peer
support groups compared to a mean change of 0 % in
the usual care group with 80 % power [28, 40]. Both
groups aged by 1 year which increased their UKPDS risk
score and we anticipated this to be offset by improve-
ments in their systolic blood pressure (SBP) and total
cholesterol/HDL cholesterol ratio, and possibly their
HbA1C and smoking status.
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The clustering of individuals by peer group arm or
usual care arm did not require any inflation of the sam-
ple size because the comparisons across clusters were
within-person changes over time and these were as-
sumed to have negligible intra-cluster correlation. To
allow for attrition we aimed to recruit 12 groups and
120 participants per arm at baseline.
Baseline demographic characteristics of the study
population were presented as means, standard deviations
(SD), frequencies and percentages based on the different
variables’ type: continuous, binary or categorical. Inde-
pendent samples t-test, chi-square test and Wilcox rank-
sum test were used to check the differences of baseline
characteristics between the intervention group and con-
trol group. Linear regression with cluster-based standard
errors was used to compare the differences of continu-
ous variables, including the UKPDS 5 yr risk, between
usual care and intervention at 12 months with adjust-
ment for baseline. Multilevel ordered logistic regression
was used to compare the changes of Patient Health
Questionnaire-9 (PHQ-9) [41] and Morisky Medication
Adherence Scale-8 (MMAS-8) [42] between usual care
and intervention from baseline to 12 months. Logistic
regression with cluster-based standard errors was used
to compare the differences of dichotomised HbA1c be-
tween usual care and intervention at 12 months with ad-
justment for baseline. To examine sensitivity of primary
outcome results to missing data the analysis of 5 yr
UKPDS risk was also conducted using multiple imputa-
tions. All analyses were completed in the Stata statistical
software package (version 13.0).
Results
Study recruitment and response rates
Figure 1 CONSORT diagram shows the sampling strat-
egy and recruitment of clusters for the study. Figure 2
describes the participant flow throughout the 12 month
intervention. Recruitment of participants occurred from
May to July 2010. From 24 locations in regional and
metropolitan Victoria, 7576 people registered with the
NDSS with T2DM were invited by mail to participate in
the study. Follow up letters were sent to 3040 of the reg-
istrants from locations in which initial response was
poor. Incorrect address details or deceased addressee re-
sulted in the return of 294 invitation letters. Expressions
of interest to participate in the study were received from
501 persons (response rate = 6.9 % (501/7282)). Of these,
441 persons were eligible to enter the study and 151 of
these people declined to participate after receiving fur-
ther study requirement details. Written informed con-
sent was obtained from 290 persons (65.7 % (290/441)
of eligible respondents). Seventeen participants withdrew
prior to the start of the intervention and thus, 273 par-
ticipants were invited to attend local or centrally located
diabetes self-management education sessions during
August to October 2010. During this time baseline mea-
sures were collected from all participants. Of these 273
participants, 33 volunteered and were deemed suitable
as peer supporters resulting in 240 peer group support
participants. Random allocation of location clusters was
undertaken in October 2010, following baseline meas-
urement and conduct of the diabetes self-management
education sessions. Training of the intervention peer
supporters took place following these steps and peer
group meetings were initiated in November 2010.
All intervention participants who attended the group
meetings were additionally invited to participate in the
process evaluation. A survey questionnaire was used at
the end of 6 and 12 months to assess: participation and re-
tention in the intervention; implementation fidelity; group
effectiveness; participants’ satisfaction with intervention
materials; participants’ willingness to continue to use the
strategies learnt through this intervention; and to assess
the extent of support provided by peers and by the re-
search team as perceived by participants. The results of
the detailed process evaluation measures will be reported
separately (Aziz et al., under preparation).
Clinical and anthropometric outcomes
Table 1 shows baseline characteristics of study participants
to be generally balanced by intervention and usual care al-
location. The median duration of diabetes was 2 years lon-
ger in intervention participants compared with usual care
participants (9 yr. vs 7 yr., p = 0.01). At baseline the mean
UKPDS for male participants was 11.5 % (SD 7.5 %) and
for females 4.2 % (SD 2.8 %). There was higher baseline
risk in the intervention arm. However, risk scores in both
study arms reduced by similar amounts over 12 months
with the difference between arms in risk changes being
zero (95 % CI −0.011, 0.011, p = 1.00; Table 2). Results of
this analysis based on multiple imputations had similar re-
sults. There were no significant differences in other clin-
ical outcomes (Table 3).
At baseline, only 16 % (17/108) usual care arm partici-
pants and 23 % (22/98) intervention arm participants
had HbA1c > 8 % (>64 mmol/mol), and 12 % (12/108)
and 13 % (11/98), respectively, had HbA1c ≥ 8.5 %
(>69 mmol/mol). Post hoc analysis showed no evidence
of a peer group support effect on changing from baseline
to 12 months the proportions of participants with either
HbA1c ≥ 8.0 % (≥69 mmol/mol), p = 0.49, or HbA1c ≥
8.5 % (≥69 mmol/mol), p = 0.47.
Behavioural and other secondary outcomes
While intervention participants showed some improve-
ment in self-reported medication adherence after
12 months of peer support, this was not significantly dif-
ferent to usual care participants (OR 2.5 (95 % CI 0.9,
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Fig. 1 CONSORT diagram (recruitment & participant flow)
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7.0, p = 0.09)). With intervention there were greater im-
provements in the number of days undertaking self-care
behaviours compared with usual care (Additional file 1:
Table S1) which included increases in the number of days
eating >5 serves of fruit and vegetables per day (p < 0.01),
participating in a specific exercise session (p = 0.03) and
testing blood sugar (p = 0.02). Both study arms showed in-
creased frequency in physical activity more than three
times per week, with the difference between them (inter-
vention 15.4 % vs. usual care 9.1 % increase) not statisti-
cally significant (p = 0.61).
Recipients of peer support also reported a significant im-
provement in the availability of (p = 0.01) and satisfaction
with support (p < 0.01) from their health care team after
12 months of the intervention, compared to the usual care
group at 12 months (Additional file 1: Table S2). No signifi-
cant improvement was observed in the intervention com-
pared to usual care group with respect to mental health or
change of depression category over time (data not shown).
Diabetes distress as measured by the brief diabetes distress
scale −4 (DDS4) was not significantly improved for those
receiving the intervention compared to those receiving
usual care (data not shown). In general, levels of distress
over the three domains investigated in our participants
were not of clinical significance given most mean measures
by study arm were below the clinical indicator of moderate
psychological distress (<3.0) [33, 43].
While intervention participants did report a slight in-
crease (5 %) in health status over time, these potential im-
provements were not significant when comparing the
weighted EuroQuol EQ5D™ index score between interven-
tion and usual care participants (p = 0.34) (data not shown).
Evaluation of diabetes self-management education
All participants received DSME prior to group alloca-
tion. Ninety four percent of participants were “very” or
“extremely satisfied” with the education session. Seventy
seven percent of the participants reported their diabetes
knowledge and understanding had “improved a lot”.
Most participants reported that they intended to change
their diabetes management after the session with 43 %
reporting intention to make changes to their diet, 33 %
Fig. 2 Individual participant flow
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reported intention to change exercise and more than
19 % reported intention to make changes to blood glu-
cose monitoring. Dietary information was reported as
most helpful by 17 % of participants; effects/conse-
quences of diabetes by 17 %, medication by 8 %, and
37 % of participants described all aspects of the DSME
as most helpful.
Evaluation of program implementation
Eleven of the 12 groups initiated and implemented the
program. One location (cluster) was allocated to receive
the program but insufficient group members were re-
cruited, hence this group joined with another location
(Fig. 1). Due to delayed initiation of this combined group
the intervention lasted only 8 months during which time
this group met on eight occasions. The other 11 groups
met at least 12 times over the 12-month period. Regular
meeting reports were obtained each month for at least the
first 6 months of the intervention from eight of the 11
groups. Additionally, verbal reports of meeting numbers
and topics discussed at the meetings were reviewed during
the weekly teleconference call between peer supporters
and members of the project team. Seven of 11 groups re-
corded an average attendance of more than 63 % of mem-
bers at the group meetings, two groups did not provide
regular data on attendance and a further two groups re-
ported an average attendance at the group meetings of 35
and 53 % over the 12-month intervention.
Healthy diet, physical activity, goal setting, problem
solving and clinical care and medication adherence were
Table 2 Five year Cardiovascular Disease Risk (UKPDS risk score) at baseline and 12 months for intervention and control groups
Participants Usual care (n = 120) Intervention (n = 120)
UKPDS risk Baseline, mean (SD) 0.075 (0.06) 0.084 (0.07)
UKPDS risk 12 months, mean (SD) 0.070 (0.06) 0.079 (0.07)
Change in UKPDS risk 12 months – baseline, mean change −0.005 (p = 0.18) −0.005 (p = 0.31)
Difference in UKPDS risk changes −0.000 (95 % CI −0.011, 0.011, p = 1.00)
Table 1 Baseline characteristics (participants)
Control(n = 120) Intervention(n = 120) Total
n Result n Result n Result
Age (mean ± SD) 115 60.5 ± 8.7 116 61.3 ± 9.3 231 60.9 ± 9.0
Sex (Male, %) 120 62 (51.7) 120 60 (50.0) 240 122 (50.8)
Metro/rural (metro, %) 120 61 (50.8) 120 59 (49.2) 240 120 (50.0)
Country of birth (Aust., %) 113 72 (63.7) 113 66 (58.4) 226 138 (61.1)
Language (English, %) 113 104 (92.0) 113 97 (85.8) 226 201 (88.9)
Ethnicity (count, %) 112 110 222
Caucasian 98 (87.5) 92 (83.6) 190 (85.6)
South East Asian 6 (5.4) 9 (8.2) 15 (6.8)
Indian sub-continent 4 (3.6) 7 (6.4) 11 (5.0)
Other 4 (3.6) 2 (1.8) 6 (2.7)
Living arrangement (count, %) 115 116 231
Single/no dependents 31 (27.0) 25 (21.6) 56 (24.2)
Single/with dependents 9 (7.8) 10 (8.6) 19 (8.2)
Married/no dependents 44 (38.3) 48 (41.4) 92 (39.8)
Married/with dependents 29 (25.2) 28 (24.1) 57 (24.7)
other 2 (1.7) 5 (4.3) 7 (3.0)
Employment (working, %) 113 50 (44.3) 113 41 (36.3) 226 91 (40.3)
Smoking status (count, %) 109 110 219
Current 6 (5.5) 12 (10.9) 18 (8.2)
Previous 42 (38.5) 43 (39.1) 85 (38.8)
Never 61 (56.0) 55 (50.0) 116 (53.0)
Median age at diagnosis 54 yr. (IQR: 46–60) 54 yr. (IQR: 46–60) 54 yr. (IQR:46–40)
Median duration of diabetes 7 yr. (IQR 3.3-10) 9 yr. (IQR: 5–12) 8 yr. (IQR: 4.5–10)
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Table 3 Mean biochemical and anthropometric measures at baseline and 12 months
Usual Care Intervention
Target Baseline
Mean ± SD (range)
12 months
Mean ± SD (range)
Mean change 95 % CI Baseline
Mean ± SD (range)
12 months
Mean ± SD (range)
Mean change 95 % CI p value*
HbA1c (%) ≤7.0 % 7.2 ± 1.3
(5–13.8)
7.3 ± 1.2
(5.1 – 12.1)
0.22 (0.02, 0.41) 7.3 ± 1.0
(5.5 – 10.3)
7.3 ± 1.1
(5.5 – 11.3)
0.06 (-0.13, 0.24) 0.53
Weight (kg) 88.0 ± 20.5
(45.4 – 169.4)
87.7 ± 19.8
(41.5 – 132.6)
−0.52 (-1.50, 0.42) 88.9 ± 17.8
(51.3 – 137.3)
87.3 ± 18.4
(52.5 – 136.9)
−0.30 (-1.06, 0.46) 0.71
BMI ≤25 31.9 ± 6.8
(17.6 - 54.1)
31.9 ± 6.7
(21.1 – 49.7)
−0.11 ( −0.46, 0.24) 31.7 ± 5.9
(18.9 - 54.9)
31.5 ± 6.2
(19.7 – 54.0)
−0.10 (−0.38, 0.17) 1.0
Waist Circum. (cm) Men <94
Women <80
106.8 ± 16.7
(64 – 153.5)
106.9 ± 16.0
(69.5 – 138)
0.9 (−0.5, 2.3) 106.9 ± 14.6
(73.5 – 145)
106.8 ± 15.7
(78.5 - 182)
1.1 (−1.2, 3.4) 0.99
SBP (mmHg) ≤130 137.4 ± 16.8
(95 – 192.7)
128.1 ± 17.1
(96–189)
−9.1 (−12.8, −5.4) 134.9 ± 15.5
(95 – 170)
130.9 ± 16.3
(98–196.7)
−5.1 (−9.1, −1.0) 0.19
DBP (mmHg) ≤80 81.4 ± 11.1
(55 – 111)
75.3 ± 11.3
(53–116.7)
−6.3 (−9.0, −3.6) 79.3 ± 10.4
(50.7 – 106.7)
74.6 ± 11.0
(47 – 110)
−4.0 (−6.6, −1.4) 0.82
Total Cholesterol <4.0 4.5 ± 1.0
(2.6 - 7.6)
4.3 ± 1.0
(2.4 – 6.8)
−0.27 (−0.43, −0.11) 4.4 ± 1.0
(2.7 - 8.5)
4.2 ± 1.0
(2.5 – 6.5)
−0.15 (−0.34, 0.04) 0.60
LDL Cholesterol <2.5 2.5 ± 0.97
(0.8 – 5.1)
2.2 ± 0.9
(0.5 – 4.1)
−0.25 (−0.40, −0.10) 2.4 ± 0.86
(1.1 - 6.0)
2.2 ± 0.8
(0.9 – 4.2)
−0.15 (−0.32, 0.02) 0.49
HDL Cholesterol >1.0 1.3 ± 0.34
(0.64 – 2.5)
1.3 ± 0.4
(0.5 – 2.5)
−0.02 (−0.07, 0.03) 1.2 ± 0.37
(0.6 – 2.5)
1.3 ± 0.4
(0.6 – 2.3)
0.03 (−0.01, 0.06) 0.31
Chol./HDL <4.5 3.7 ± 1.1
(1.5 - 7.6)
3.6 ± 1.3
(1.7 – 9.8)
−0.09 (−0.30, 0.11) 3.8 ± 1.2
(1.8 - 7.3)
3.5 ± 1.2
(1.8 – 7.7)
−0.22 (−0.41, −0.03) 0.29
LDL-HDL <3.7 2.0 ± 1.0
(0.4 – 5.4)
1.9 ± 1.0
(0.4 – 6.8)
−0.10 (−0.27, 0.06) 2.0 ± 0.9
(0.6 – 4.8)
1.8 ± 0.8
(0.7 – 4.3)
−0.16 (−0.32, -0.01) 0.33
Triglycerides <1.5 1.7 ± 0.8
(0.5 – 5.4)
1.7 ± 1.0
(0.5 – 5.5)
0.07 (−0.10, 0.24) 1.7 ± 0.9
(0.5 – 5.8)
1.6 ± 0.9
(0.6 – 5.0)
0.09 (−0.08, 0.25) 0.82
*p-value is calculated for comparing mean change between groups
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regularly discussed during at least three meetings in all
groups. Mental health and coping skills were discussed at
least once by all groups. In addition to regular phone con-
tact between peer supporters and their group participants,
seven of the 11 groups also had regular interaction outside
the formal group sessions, including regular walking as a
group, Tai Chi class and/or social meetings outside the
group meeting. Additional interactions were reported or-
ally during the teleconference by peer supporters and their
frequency was group dependent. Organised walks by one
group occurred at least once between group meetings
during the intervention period. Tai-Chi classes occurred
for one group approximately every second month. Social
meetings outside the group consisted of activities such as
meeting for coffee or opportunistic interaction in commu-
nity settings such as during shopping. Only one group re-
ported discussing sexual health during their group
sessions. Eight of the 11 groups reported visits to their for-
mal group sessions from two or more local health or allied
health professionals, including doctors, psychologists,
sports physiologists, pharmacists, podiatrists, diabetes ed-
ucators and dieticians.
Discussion
In this “real world” trial we evaluated the outcomes and
implementation of community based lay peer led sup-
port groups on cardiovascular disease risk, biochemical
and anthropometric measures and self-management be-
haviours among participants with T2DM. Even though
there were positive changes on some key self-
management behaviours, these were not sufficient to re-
duce cardiovascular disease risk after 12 months. Both
the intervention and the usual care groups showed small
improvements in most of the biochemical and anthropo-
metric outcomes. There are three explanations for our
findings: firstly, peer support as delivered in our pro-
gram was not effective in improving clinical outcomes
such as HbA1c; secondly, program exposure in our
intervention was not sufficient to effect change in inter-
vention participants; or thirdly, the study participants re-
cruited for this trial were already quite well controlled
and hence, there was an insufficient number of those
whose control was poor in order to detect a significant
difference in the main study outcomes. Most likely, our
study findings resulted from a combination of these
three explanations which are discussed below.
There is increasing evidence that peer and professionally
delivered behavioural interventions such as peer health
coaching and support or individual diabetes education by
health professionals may be more beneficial for patients
with lower medication adherence and self-management
levels [23], or poor glycaemic control, as indicated by
HbA1c greater than 8 % [44–46]. However, any improve-
ment in medication adherence in our study, did not
translate to improved clinical outcomes such as reduced
HbA1c or lipid measures. Furthermore, a post hoc analysis
of those study participants with poorer control at baseline
found no significant benefit of peer support for these partic-
ipants, although the number of study participants who were
poorly controlled at baseline was quite small.
While the average proportion of participants attending
monthly group meetings in this “real world” trial was 63 %
or less, several studies have suggested that programs with
higher contact and intensity are likely to achieve better
clinical outcomes and improvement in diabetes related
self-management behaviours [24, 47]. However, half of our
study participants already had quite good diabetes control
as well as a good level of diabetes knowledge and most
had visited their health care provider and had had their
HbA1c tested at least once in the six months prior to the
beginning of the study [48]. Additionally, all recruited par-
ticipants received an intensive day of diabetes self-
management education as well as a comprehensive educa-
tion resource manual prior to allocation of clusters which
may have contributed to some of the improvements ob-
served within the usual care group [49].
Notwithstanding the lack of significance in clinical
outcomes, it is important to note that intervention par-
ticipants in our trial did report some positive lifestyle
changes. Participants reported increased physical activity
and fruit and vegetable consumption. And participants
also reported increased satisfaction with support from
health care providers.
An earlier review of behavioural interventions for life-
style change undertaken by Oldenburg and Absetz [50]
showed that more comprehensive interventions are gen-
erally more effective in disease management than single
behavior-focused interventions, and the same applies for
more intensive and longer interventions. Furthermore,
longer term and more sustained follow-up is also critical
to enhance maintenance of the changes [50]. Although
the intervention program evaluated in this trial certainly
incorporated strategies addressing each of the lifestyle
and self-care behaviours that are linked to T2DM and its
ongoing management, there was considerable variability
in the program dose received by study participants
across the groups. Therefore, while the program
evaluated in this trial was “real world” and it would be
feasible for wider implementation, perhaps the dose and
intensity was insufficient for achieving significant out-
comes, even among those with poorer adherence and
control. Moreover, maintaining participant’s involvement
and engagement during the intervention (such as regular
attendance at group meetings and supporting each
other), could be an important determining factor for the
successful delivery of diabetes self-management inter-
ventions particularly for those whose diabetes is less well
controlled.
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A key strength of this study was the “real world” nature
of the program and its delivery by lay people with dia-
betes. This is a very important issue for future program
scalability because it is probably not feasible for the health
care system to provide such programs directly to all
people with diabetes or potentially even, those who have
poor control and other difficulties with diabetes self-
management. At least within the Australian context, non-
government organisations such as Diabetes Australia are
often relied upon to support the development and on-
going management of these programs. Another strength
of our study is the fact that the evaluation design also
allowed for a thorough evaluation of its impact and its
future potential for scalability.
Eleven of the 12 proposed community based peer
groups were initiated and remained active for at least
12 months. With several groups continuing to meet after
the final measurements were collected. Thus, we have
demonstrated that it is possible to develop and imple-
ment a “real world” community based peer support pro-
gram for people with T2DM which enables members to
make at least some changes in diabetes self-management
behaviours such as physical activity and diet. We also
observed some significant improvement in the satisfac-
tion and perception of support from diabetes health care
team, which may assist in improving the collaborative
relationship between patient and health care team and
thus, also improve medication adherence in the future.
As demonstrated by our relatively low crude response
rate (6.9 %) recruitment via the national register for
people with diabetes in Australia, while feasible and cost
effective, may not be appropriate for reaching those indi-
viduals with poor diabetes control and also experiencing
other difficulties.
The major study limitation was the low response rate
and the fact that almost half of those individuals recruited
already had reasonably good glycaemic control. This is
despite the fact that our recruitment method of sending a
direct mail invitation to registrants of a National Diabetes
registry (such as might be the method used in a “real
world” community based program) is cost effective and
the crude response rate (6.9 %) from this method is similar
to that reported in previous studies [51].
Unfortunately, two of the intervention groups did not
provide regular data on meeting details, so this made it
difficult to calculate an accurate and reliable measure of
program exposure for all groups and all participants.
However, program exposure was quite modest in some
of the groups and likely to be of insufficient intensity for
those experiencing difficulties with diabetes control and
related problems.
Several studies in the global Peers for Progress program
whose participants included those from disadvantaged com-
munities with poorer diabetes control report benefits of peer
support or health coaching directly on HbA1c [8, 52] or on
cardiovascular risk factors [53, 54]. Interestingly those pro-
jects conducted in populations with better access to either
privately or publicly funded health care did not appear to
benefit significantly with respect to clinical health outcomes
from additional peer support [11, 15, 22].
Despite these various findings and our own results, peer
support programs have been shown to be feasible and ac-
ceptable at the community level and probably provide
some important benefits and outcomes, particularly for
those “hard to reach” patient groups [25]. However, im-
portant questions still remain about how to better target
those subgroups that might derive greater benefit from
peer support, such as those who have higher HbA1c
levels, those who have poor medication adherence and
those who are experiencing other difficulties with diabetes
self-management and living with diabetes.
Conclusions
In summary, we report here on the real world imple-
mentation of a community-based, lay led peer support
program which aimed to train and support lay people to
provide structured support and help to people with dia-
betes in order to improve diabetes self-management. Al-
though there were some modest benefits in terms of
healthy behaviors and participants’ reports of satisfaction
with their care, it did not improve clinical outcomes for
the majority of participants. Future research needs to
focus more on how this kind of program and delivery
model could be used to provide more structure support
and help to those individuals with diabetes who have
poor diabetes control and who are experiencing other
significant difficulties living with diabetes.
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